Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/17/2024 | Neutral | BTIG Research | |
| 5/14/2024 | $8.25 → $5.00 | Outperform → Market Perform | Leerink Partners |
| 11/11/2022 | $4.00 | Overweight → Neutral | Piper Sandler |
| 6/16/2022 | $17.00 → $8.50 | Overweight → Equal-Weight | Morgan Stanley |
| 11/23/2021 | $18.00 | Outperform | Raymond James |
| 11/23/2021 | $17.00 | Overweight | Morgan Stanley |
| 11/23/2021 | $26.00 | Outperform | SVB Leerink |
| 11/23/2021 | $22.00 | Overweight | Piper Sandler |
BTIG Research initiated coverage of AirSculpt Technologies with a rating of Neutral
Leerink Partners downgraded AirSculpt Technologies from Outperform to Market Perform and set a new price target of $5.00 from $8.25 previously
Piper Sandler downgraded AirSculpt Technologies from Overweight to Neutral and set a new price target of $4.00
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
3 - Airsculpt Technologies, Inc. (0001870940) (Issuer)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G/A - Airsculpt Technologies, Inc. (0001870940) (Subject)
SC 13G - Airsculpt Technologies, Inc. (0001870940) (Subject)
144 - Airsculpt Technologies, Inc. (0001870940) (Subject)
144 - Airsculpt Technologies, Inc. (0001870940) (Subject)
10-Q - Airsculpt Technologies, Inc. (0001870940) (Filer)
MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer environment," said Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer of AirSculpt Technologies, Inc. "We are pleased with our four new center openings during the quarter and our 2023 de novo class continues to surpass ou
Expects 2024 Revenue in the Range of $183 Million to $189 Million Announces Third Quarter Fiscal 2024 Earnings Date and Conference Call MIAMI BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced selected unaudited preliminary financial results for its third quarter ended September 30, 2024. For the third quarter, revenue is expected to be approximately $42.5 million, a decrease of approximately 9% over the prior year. Same store cases declined 8.1% over the prior year period. "While we continue to see top line pressures primarily from macro-econo
MIAMI BEACH, Fla., Oct. 1, 2024 /PRNewswire/ -- AirSculpt® Technologies, Inc., ("AirSculpt") (NASDAQ:AIRS) an industry leader and provider of premium body contouring procedures, today announced the opening of its Birmingham office at 555 S. Old Woodward Avenue Suite 500, Birmingham, MI 48009, increasing its center count to 31 locations. The center has been artfully designed and is complete with two operating rooms allowing for concurrent procedures. Also, the company's popular AirSculpt®+ skin tightening procedure has been brought to the clinic's list of offerings. "We are ex
MIAMI BEACH, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the third quarter and nine months ended September 30, 2024. "Our revenue and Adjusted EBITDA for the quarter were in line with our expectations with the period including progress on our strategy despite continued challenges in the consumer environment," said Dennis Dean, Interim Chief Executive Officer and Chief Financial Officer of AirSculpt Technologies, Inc. "We are pleased with our four new center openings during the quarter and our 2023 de novo class continues to surpass ou
Expects 2024 Revenue in the Range of $183 Million to $189 Million Announces Third Quarter Fiscal 2024 Earnings Date and Conference Call MIAMI BEACH, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced selected unaudited preliminary financial results for its third quarter ended September 30, 2024. For the third quarter, revenue is expected to be approximately $42.5 million, a decrease of approximately 9% over the prior year. Same store cases declined 8.1% over the prior year period. "While we continue to see top line pressures primarily from macro-econo
Second Quarter Revenue of $51.0 million, Net Loss of $3.2 million and Adjusted EBITDA of $6.9 million Company Revises 2024 Guidance MIAMI, Aug. 09, 2024 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS) ("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced results for the second quarter and first six months ended June 30, 2024. The Company also announced that Dennis Dean, Chief Financial Officer of the Company has assumed the position of Interim Chief Executive Officer as Todd Magazine has resigned from the Chief Executive Officer role and as a member of the Board of Directors. Mr. Magazine
Leerink Partners analyst Whit Mayo downgrades AirSculpt Technologies (NASDAQ:AIRS) from Outperform to Market Perform and announces $5 price target.
AirSculpt Technologies (NASDAQ:AIRS) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.02) by 250 percent. This is a 70 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $47.62 million which missed the analyst consensus estimate of $49.80 million by 4.38 percent. This is a 3.94 percent increase over sales of $45.81 million the same period last year.